METHODS OF TREATING SQUAMOUS CELL CARCINOMA RELATED APPLICATIONS

IPC classification:

G01N 33/574

Applicant:

Novartis AG

Agent:

David Richard Spinner, Novartis Pharma AG

Status:

█ APPLICATION DEEMED TO BE WITHDRAWN

SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA

IPC classification:

C12Q 1/48

Agent:

David Richard Spinner, Greaves Brewster LLP

Agent:

Philippe Ahner, Brevalex

Status:

█ APPLICATION DEEMED TO BE WITHDRAWN

METHOD OF TREATING VISION DISORDERS

IPC classification:

C07K 16/22, A61P 27/02

Applicant:

Novartis AG

Agent:

Multiple attorneys, Novartis Pharma AG

Status:

█ APPLICATION DEEMED TO BE WITHDRAWN

DEVICE FOR MANUFACTURING POLYMER FIBERS AND USES THEREOF

IPC classification:

A61L 33/06, D01D 5/38, D01D 5/30, B29C 47/00

Applicant:

Agency for Science, Technology and Research

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ GRANT OF PATENT INTENDED

METHOD OF TREATING AN OCULAR DISEASE AND COMPOSITIONS EFFECTIVE FOR TREATING AN OCULAR DISEASE

IPC classification:

A61K 38/13

Applicant:

Howard University

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION IN PROGRESS

SELECTIVE BINDING OF BIOLOGICAL TARGETS TO SOLID PHASE UREIDES

IPC classification:

G01N 33/48, C12N 7/02, B01D 15/00

Applicant:

Agency for Science, Technology and Research

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ The patent has been granted

MIXED MULTIFUNCTIONAL METAL AFFINITY SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS FIELD

IPC classification:

C07K 1/18, C07C 259/06, C07C 233/47, C07C 211/14, C07C 55/22, C07C 55/02, B01D 39/00, B01D 15/38, B01D 15/36

Applicant:

Agency for Science, Technology and Research

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ GRANT OF PATENT INTENDED

RECONSTITUTION DEVICE

IPC classification:

A61M 5/315, A61M 5/28

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ APPLICATION DEEMED TO BE WITHDRAWN

INDUCTION OF ESTROGEN RECEPTOR BETA BY CHOLESTEROL BIOSYNTHESIS INHIBITORS AND METHODS OF TREATMENT OF CANCER

IPC classification:

A61K 31/5685, A61K 31/56, A61P 35/00

Applicant:

University Of Missouri

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION IN PROGRESS

ANTIBODIES TO TAU

IPC classification:

G01N 33/53, C07K 16/18

Applicant:

Washington University

Agent:

J A Kemp

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ GRANT OF PATENT INTENDED

SALMONID ALPHAVIRUS AND USES THEREOF

IPC classification:

A61K 39/12, G01N 33/569, C07K 14/18

Applicant:

Novartis Tiergesundheit AG

Agent:

Sean Matthew Alexander, Eli Lilly and Company Limited

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ PATENT GRANTED

GROUPING FOR CLASSIFYING GASTRIC CANCER

IPC classification:

G01N 33/574, C12Q 1/68

Applicant:

Agency for Science, Technology and Research

Applicant:

National University of Singapore

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ GRANT OF PATENT INTENDED

FLAVIVIRUS ASSOCIATED WITH THEILER'S DISEASE

IPC classification:

C12Q 1/68, C07K 14/005

Applicant:

Center for Technology Licensing (CTL) at Cornell University

Applicant:

Novartis Tiergesundheit AG

Applicant:

Cornell University

Agent:

Sean Matthew Alexander, Eli Lilly and Company Limited

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ The patent has been granted

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:

A61K 45/00

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ GRANT OF PATENT INTENDED

CELL LINE AND METHODS FOR IMPROVED GLYCOPROTEIN SIALYLATION

IPC classification:

C12P 21/06, C12P 21/04, C12N 15/113, C12N 9/24

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION IN PROGRESS

A POLYMERIC SYSTEM FOR RELEASE OF AN ACTIVE AGENT

IPC classification:

A61K 47/48, A61K 47/30, A61L 27/50, A61L 27/44

Applicant:

Agency for Science, Technology and Research

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

INTERACTIONS OF BETANODAVIRUSES IN INFECTION

IPC classification:

A61K 39/12

Applicant:

University of Málaga (Universidad de Malaga)

Applicant:

Novartis Tiergesundheit AG

Agent:

Sean Matthew Alexander, Eli Lilly and Company Limited

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ GRANT OF PATENT INTENDED

METHODS FOR PREPARING INACTIVATED ROTAVIRUS

IPC classification:

C12N 7/00, A61K 39/12

Applicant:

Novartis Tiergesundheit AG

Agent:

Sean Matthew Alexander, Eli Lilly and Company Limited

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION IN PROGRESS

PLANTS HAVING ENHANCED YIELD-RELATED TRAITS AND A METHOD FOR MAKING THE SAME

IPC classification:

C12N 15/82

Applicant:

BASF Plant Science Company GmbH

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ APPLICATION PUBLISHED

SYNTHETIC POLYMERIC MATERIALS AND DEVICES THEREOF

IPC classification:

C08G 63/91, C08L 43/04, C08G 77/20

Applicant:

Colorado State University Research Foundation

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ GRANT OF PATENT INTENDED

SEMI-AUTOMATIC SPHYGMOMANOMETER SYSTEM

IPC classification:

A61B 5/0225

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ GRANT OF PATENT INTENDED

IMMUNOASSAYS USING OVER-LABELED FLUORESCENT PROBES

IPC classification:

G01N 33/53

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ GRANT OF PATENT INTENDED

INTRA-AMNIOTIC ADMINISTRATION OF PROTEINS FOR THE TREATMENT OF ECTODERMAL DYSPLASIAS

IPC classification:

A61K 38/00, A61K 39/00

Applicant:

University of Erlangen-Nürnberg (Friedrich-Alexander-Universität Erlangen-Nürnberg)

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

METHOD FOR TREATMENT OF DEMYELINATING CENTRAL NERVOUS SYSTEM DISEASE

IPC classification:

A61K 38/21, C07K 14/535, A61P 37/00, A61P 25/28, A61P 25/00, A61K 38/19

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ APPLICATION DEEMED TO BE WITHDRAWN

METHODS OF DETERMINING AMYLOID BETA TURNOVER IN BLOOD

IPC classification:

G01N 33/68, G01N 33/48, A61B 5/00

Applicant:

Washington University

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ The patent has been granted

MICRO RNA ISOLATION FROM BIOLOGICAL FLUID

IPC classification:

G01N 33/566, C12Q 1/68, G01N 33/53, C07H 21/04

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

BIOMARKERS AND METHODS RELATING TO ALZHEIMER'S DISEASE

IPC classification:

G01N 33/68

Applicant:

King's College London

Agent:

Matthew David Greenwood, Bryers LLP

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF AMINO ACIDS IN HYDROGENOTROPHIC MICROORGANISMS

IPC classification:

C12R 1/01

Agent:

Anna Louise Gregson, Mathys & Squire LLP

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

OLIGONUCLEOTIDES FOR MAKING A CHANGE IN THE SEQUENCE OF A TARGET RNA MOLECULE PRESENT IN A LIVING CELL

IPC classification:

A61K 31/7088, A61K 48/00, C12N 15/11

Agent:

David Richard Spinner, Greaves Brewster LLP

Agent:

Carpmaels & Ransford LLP

Status:

█ Request for examination was made

ACETAMINOPHEN PROTEIN ADDUCTS AND METHODS OF USE THEREOF

IPC classification:

A61K 31/167

Applicant:

University of Arkansas

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

INTEGRATED CELLULOSIC ETHANOL PRODUCTION PROCESS

IPC classification:

A23L 7/104, A23L 29/30, A23L 29/212, C12P 7/10, C12P 7/06, C12N 1/16

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:

C12N 9/22, C12N 15/63, C12N 15/10

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ APPLICATION PUBLISHED

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:

C12N 9/22, C12N 15/63, C12N 15/10

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION IN PROGRESS

EPIGENETIC MODIFICATION OF MAMMALIAN GENOMES USING TARGETED ENDONUCLEASES

IPC classification:

C12Q 1/02, C12Q 1/68

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:

C12N 9/22, C12N 15/63, C12N 15/10

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:

C12N 9/22, C12N 15/63, C12N 15/10

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ APPLICATION PUBLISHED

PROCESS FOR THE PREPARATION OF A C5-ENRICHED JUICE STREAM

IPC classification:

C08B 30/00

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:

C12N 9/22, C12N 15/63, C12N 15/10

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ The patent has been granted

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:

C12N 9/22, C12N 15/63, C12N 15/10

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ APPLICATION PUBLISHED

TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES

IPC classification:

C12N 15/62, A61P 35/00, C07K 16/32, A61K 38/21

Applicant:

University of California

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

BOTTOM LOADED PEDICLE SCREW

IPC classification:

A61B 17/70

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ EXAMINATION REQUESTED

ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS

IPC classification:

A01P 1/00, A61P 31/00, A01N 43/50, A61K 31/4178, C07D 233/56

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

BIOMARKERS OF OSTEOARTHRITIS

IPC classification:

G01N 33/53, C12Q 1/68

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ The application has been published

TAU KINETIC MEASUREMENTS

IPC classification:

G01N 33/58, G01N 33/68, A61K 51/02, A61K 51/08

Applicant:

Washington University

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

GLYCAN ANALYSIS AND PROFILING

IPC classification:

C40B 40/12

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

OLIGONUCLEOTIDES FOR GENOMIC DNA EDITING

IPC classification:

A61K 31/7088, C12N 15/11

Agent:

David Richard Spinner, Greaves Brewster LLP

Agent:

Carpmaels & Ransford LLP

Status:

█ Request for examination was made

GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE

IPC classification:

C07K 16/00, A61K 39/00, A61K 39/395

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

TARGETED RNA EDITING

IPC classification:

C12N 15/113

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

VISUALIZING MODIFIED NUCLEOTIDES AND NUCLEIC ACID INTERACTIONS IN SINGLE CELLS

IPC classification:

G01N 33/50, C12Q 1/68, C12N 15/09

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

NANOCAPSULES CARRYING CHIKUNGUNYA-ASSOCIATED PEPTIDES

IPC classification:

A61K 9/51, C07K 19/00, C07K 14/18, A61K 39/12

Applicant:

Nanyang Technological University

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

HIGH SENSITIVITY METHOD FOR EARLY LYME DISEASE DETECTION

IPC classification:

G01N 33/569, G01N 27/62, G01N 30/72

Applicant:

Colorado State University Research Foundation

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

METHODS AND COMPOSITIONS FOR EXPANSION AND DIFFERENTIATION OF SKELETAL MUSCLE STEM CELLS OR PROGENITOR CELLS

IPC classification:

C12N 5/077

Applicant:

Agency for Science, Technology and Research

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

OLIGONUCLEOTIDE THERAPY FOR LEBER CONGENITAL AMAUROSIS

IPC classification:

A61K 31/7125, A61K 31/712, C12N 15/113

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

OLIGONUCLEOTIDES MATCHING COL7A1 EXON 73 FOR EPIDERMOLYSIS BULLOSA THERAPY

IPC classification:

A61K 31/7125, A61K 31/712, C12N 15/113

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

USING PROGRAMMABLE DNA BINDING PROTEINS TO ENHANCE TARGETED GENOME MODIFICATION

IPC classification:

C12N 9/22, C12N 15/10

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF METHIONINE

IPC classification:

C12M 1/00, C07K 14/195, C12N 9/88, C12N 9/02, C12P 13/12

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

ANTISENSE OLIGONUCLEOTIDES TO TREAT DYSTROPHIC EPIDERMOLYSIS BULLOSA

IPC classification:

A61K 31/7088, A61P 17/00, C12N 15/113

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

METHODS FOR NEXT GENERATION GENOME WALKING AND RELATED COMPOSITIONS AND KITS

IPC classification:

C40B 20/04, C07H 21/04, C12P 19/34, C12Q 1/68

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ Request for examination was made

FUTURE CARDIAC EVENT BIOMARKERS

IPC classification:

A61P 9/00, G01N 33/68

Applicant:

Leiden University (Universiteit Leiden)

Applicant:

Leiden University Medical Center (Leids Universitair Medisch Centrum (LUMC) - Academisch Ziekenhuis Leiden)

Agent:

David Richard Spinner, Greaves Brewster LLP

Status:

█ The application has been published